Press Releases Latest Jul 23, 2021 Theratechnologies Establishes New At-The-Market Facility Press Releases Year None202120202019201820172016201520142013 Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population Sep 10, 2020 Theratechnologies Announces Launch Of Trogarzo® In Germany Jul 30, 2020 Theratechnologies To Present At The Canaccord Genuity 40th Annual Growth Conference On August 12, 2020 Jul 23, 2020 Theratechnologies Reports That Tesamorelin Improves Liver Health Jul 16, 2020 Announcements In Conjunction With Theratechnologies Annual Meeting Jul 15, 2020 Theratechnologies Announces Financial Results For The Second Quarter Of Fiscal 2020 Jul 07, 2020 Theratechnologies Confirms Bioequivalence Of New Tesamorelin Formulation Jul 06, 2020 Theratechnologies Announces Ibalizumab Inhibits HIV-2 In Vitro Jun 26, 2020 Theratechnologies To Announce Financial Results For Second Quarter 2020 Jun 22, 2020 New Data Show Theratechnologies’ SORT1+ Technology Is Effective In Many Treatment-Resistant Cancers First page « Previous page ‹ Page 1 Page 2 Page 3 Page 4 Current page 5 Page 6 Page 7 Page 8 Page 9 … Next page › Last page » Displaying 41 - 50 of 253
Sep 10, 2020 Theratechnologies To Develop Tesamorelin For The Treatment Of Nash In The General Population
Jul 30, 2020 Theratechnologies To Present At The Canaccord Genuity 40th Annual Growth Conference On August 12, 2020
Jun 22, 2020 New Data Show Theratechnologies’ SORT1+ Technology Is Effective In Many Treatment-Resistant Cancers
